Explore more publications!

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on April 1, 2026

Drilling Resumes on Globex’s Berrigan Zinc, Gold, Silver Royalty Property NW of Chibougamau, Quebec
ParaZero Secured an Order Valued at Over $650,000 From a Tier-1 International Drone Interception Company
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
GoldHaven Advances 2026 Drill Targeting at Magno; Permit Application Submitted
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
Latin Metals Provides Update on Expanded Cerro Bayo Drill Program
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Nexxen Announces March 2026 Share Repurchase Program Summary
Skyharbour Announces Drilling Underway and Renewed Permit at the High-Grade Moore Lake Uranium Project, Saskatchewan
Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
Nexera Technologies Reports Full Year 2025 Revenue Growth to $16.83 Million Driven by Strong Second Half Performance of $9.85 Million
Midland and SOQUEM Are Planning an Induced Polarization Survey on the Malaco Mountain Copper-Gold-Rare Earth Element Zone in the Labrador Trough
Midland et SOQUEM planifient un levé de polarisation provoquée sur la zone de cuivre, or et Éléments de Terres Rares de Malaco Mountain dans la Fosse du Labrador
Rio Silver Inc. Generates Royalty Revenue and Confirms Additional Upcoming Share Issuance from Magma Silver
Avicanna Reports Full Year 2025 Audited Financial Statements
DEEP SEA MINERALS CORP. ANNOUNCES MARKETING ENGAGEMENT
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions